Multiplex Testing: FDA Solicits Guidance, Device Submissions From Industry
This article was originally published in The Gray Sheet
Executive Summary
CDRH is considering drafting a separate guidance for multiplex tests and microarrays that would focus on issues related to quality system regulations and good manufacturing practices